Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated May 21, 2025 (17 months ago)

Tirzepatide Injections

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112

Drug: Tirzepatide

Recalling firm
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
Origin
CO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0484-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Tirzepatide recalls

See all

Other recalls by Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

All 2025 recalls